FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

19338005: 2 (qualifier value)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    32597014 Two en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442102012 2 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442103019 2 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    2 Is a General adjectival modifier false Inferred relationship Some
    2 Is a Number false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely sodium fluoride 2 milligram/1 gram conventional release oromucosal solution (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely ibuprofen 50 milligram/1 gram and levomenthol 30 milligram/1 gram conventional release cutaneous gel (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Lactic acid 50 mg/g and urea 100 mg/g cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some
    Product containing only vitamin A 4000 iu and vitamin D 400 iu/1 each oral capsule Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely dithranol 2.5 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous gel (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely betamethasone dipropionate 640 microgram/1 gram and clotrimazole 10 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some
    Hydrocortisone 10 mg/g and oxytetracycline (as oxytetracycline hydrochloride) 30 mg/g cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release solution for ear or eye drops Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely carbomer-980 2 milligram/1 gram conventional release eye gel (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely hydrocortisone acetate 10 milligram/1 gram and sodium fusidate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely benzoic acid 60 milligram/1 gram and salicylic acid 30 milligram/1 gram conventional release cutaneous cream (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Hydrocortisone 2 mg/g and lidocaine hydrochloride 10 mg/g cutaneous spray Count of base of active ingredient False 2 Inferred relationship Some
    Fusidic acid 20 mg/g and hydrocortisone acetate 10 mg/g cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely benzoyl peroxide 50 milligram/1 gram and clindamycin (as clindamycin phosphate) 10 milligram/1 gram conventional release cutaneous gel (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel Count of base of active ingredient False 2 Inferred relationship Some
    Econazole nitrate 10 mg/g and hydrocortisone 10 mg/g cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some
    Hydrocortisone 10 mg/g and miconazole nitrate 20 mg/g cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely hydrocortisone 10 milligram/1 gram and miconazole nitrate 20 milligram/1 gram conventional release cutaneous cream (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Dexamethasone 1 mg/mL and tobramycin 3 mg/mL eye drops Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely benzoyl peroxide 50 milligram/1 gram and potassium hydroxyquinoline sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Fluprednidene acetate 1 mg/g and miconazole nitrate 20 mg/g cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 2
    Product containing precisely clotrimazole 10 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some
    Epinephrine 5 mg/mL and guanethidine monosulfate 30 mg/mL eye drops Count of base of active ingredient False 2 Inferred relationship Some
    Allantoin 20 mg/g and coal tar extract 50 mg/g cutaneous lotion Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely chlorhexidine gluconate 2 milligram/1 milliliter conventional release oromucosal spray (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1
    Adrenaline 2 mg/mL and guanethidine monosulfate 10 mg/mL eye drops Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely allantoin 20 milligram/1 gram and coal tar extract 50 milligram/1 gram conventional release cutaneous cream (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Clioquinol 30 mg/g and hydrocortisone 10 mg/g cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release solution for ear or eye drops Count of base of active ingredient False 2 Inferred relationship Some
    Lidocaine 70 mg/g and tetracaine 70 mg/g cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some
    Benzoyl peroxide 100 mg/g and potassium hydroxyquinoline sulfate 5 mg/g cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Cetrimide 150 mg/mL and chlorhexidine gluconate 15 mg/mL cutaneous solution Count of base of active ingredient False 2 Inferred relationship Some
    Cod liver oil 114 mg/g and zinc oxide 380 mg/g cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely benzalkonium chloride 100 microgram/1 gram and cetrimide 2 milligram/1 gram conventional release cutaneous cream (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely benzalkonium chloride 100 microgram/1 gram and cetrimide 2 milligram/1 gram conventional release cutaneous cream (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Count of base of active ingredient False 2 Inferred relationship Some
    Chlorhexidine hydrochloride 10 mg/g and nystatin 100000 unit/g cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely latanoprost 50 microgram/1 milliliter and timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye drops (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Benzocaine 10 mg/g and triclosan 2 mg/g cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely neomycin 3.5 milligram/1 milliliter and triamcinolone acetonide 1 milligram/1 milliliter conventional release ear drops (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Adapalene 1 mg/g and benzoyl peroxide 25 mg/g cutaneous gel Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some
    Benzalkonium chloride 1 mg/g and dimeticone 220 mg/g cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Some
    Alverine citrate 5 mg/g and Sterculia gum 620 mg/g oral granules Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely mineral oil 50 milligram/1 gram and white petrolatum 950 milligram/1 gram conventional release cutaneous ointment (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Cetrimide 3 mg/g and dimeticone 1000 100 mg/g cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely alfacalcidol 2 microgram/1 milliliter conventional release oral drops (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1
    Rivastigmine (as rivastigmine tartrate) 2 mg/mL oral solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely lidocaine 25 milligram/1 gram and prilocaine 25 milligram/1 gram conventional release cutaneous cream (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely brimonidine tartrate 2 milligram/1 milliliter conventional release eye drops (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely potassium bicarbonate 20 milligram/1 milliliter and sodium alginate 100 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Clioquinol 10 mg/mL and flumetasone pivalate 200 microgram/mL ear drops Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely haloperidol 2 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely mineral oil 500 milligram/1 gram and white petrolatum 500 milligram/1 gram conventional release cutaneous ointment (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely dextran 70 1 milligram/1 milliliter and hypromellose 3 milligram/1 milliliter conventional release eye drops (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely glyceryl trinitrate 2 milligram/1 gram conventional release rectal ointment (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1
    Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream Count of base of active ingredient False 2 Inferred relationship Some
    Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Crotamiton 100 mg/g and hydrocortisone 2.5 mg/g cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely propranolol hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1
    Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some
    Betamethasone (as betamethasone valerate) 1 mg/g and neomycin sulfate 5 mg/g cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous cream (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely lauromacrogol 30 milligram/1 gram and urea 50 milligram/1 gram conventional release cutaneous cream (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely benzalkonium chloride 1 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Heparinoid 2 mg/g and lauromacrogol 400 50 mg/g rectal ointment Count of base of active ingredient False 2 Inferred relationship Some
    Heparinoid 2 mg/g and lauromacrogol 400 50 mg/g rectal ointment Has concentration strength numerator value False 2 Inferred relationship Some 2
    Product containing precisely cetylpyridinium chloride 1 milligram/1 gram and lidocaine hydrochloride 3.3 milligram/1 gram conventional release dental gel (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Hydrocortisone 10 mg/g and urea 100 mg/g cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 milliliter and hydrocortisone acetate 10 milligram/1 milliliter conventional release ear drops (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Tamoxifen (as tamoxifen citrate) 2 mg/mL oral solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Temazepam 2 mg/mL oral solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely nystatin 100000 unit/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Colloid sulfur 80 mg/g and resorcinol 20 mg/g cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some
    Selegiline hydrochloride 2 mg/mL oral solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release solution for cutaneous spray Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely chlorhexidine gluconate 2 milligram/1 milliliter conventional release oromucosal solution (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely chlorhexidine hydrochloride 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Chlorhexidine gluconate 1 mg/mL and chlorobutanol 5 mg/mL oromucosal solution Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely Podophyllum resin 200 milligram/1 gram and salicylic acid 250 milligram/1 gram conventional release cutaneous ointment (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Benzocaine 10 mg/g and triclosan 2 mg/g cutaneous cream Has concentration strength numerator value False 2 Inferred relationship Some 1
    Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream Has concentration strength numerator value False 2 Inferred relationship Some 1

    Start Previous Page 7 of 24 Next End


    Reference Sets

    Concept inactivation indicator reference set

    Back to Start